Insights
One specific point per article, drawn from what several experts said across different podcasts: where they agree, where they don't, and what to do with it. Every claim links back to the episode it came from.
Short on time? Cheat sheets and flashcards for the insights.
FiltersGeneticsLongevitySupplements Peptides HormonesClear
Pick as many as you like: any of them matches within a group.
13 insights
Growth hormone: the youth hormone that may not lengthen life
Clinics offer growth hormone and drugs that release it to restore youthful muscle and skin, and Kyle Gillett and Craig Koniver describe using them, yet David Sinclair notes that lower growth signaling goes with longer life and Huberman lists the risks of injecting it. The contrast shows why feeling younger and living longer are not always the same goal.
Peptides: promising, poorly tested and often gray-market
Craig Koniver uses peptides clinically, while Huberman's review stresses thin human evidence, tumor questions and sourcing risks, and his growth hormone episode warns about injections. It shows why physician oversight matters in a fast-growing, loosely regulated field.
Which blood tests to get, and when to start
Casey Means, Sara Gottfried, Kyle Gillett and Peter Attia each lay out biomarkers worth tracking by age and sex, from glucose and insulin to hormones and lipids. Starting a baseline early lets you catch drift years before disease.
Can you inherit your parents' experiences? Epigenetics hype versus the evidence
Oded Rechavi shows small RNAs carry acquired traits across generations in worms, while David Linden warns that many human epigenetic claims outrun the data and David Sinclair frames aging itself as lost epigenetic information. Knowing where the solid evidence ends helps readers judge viral claims about inherited trauma and lifestyle.
Genes load the gun, environment pulls the trigger: nature and nurture reframed
Experts on obesity, autism, individuality and hormones all describe traits as genetic predispositions that the environment either triggers or restrains, and warn that heritability is widely misunderstood. It matters because it replaces fatalism with a clearer sense of what we can and cannot change.
Critical windows: why early development locks in so many traits
From accents learned in childhood to hormone-driven sexual development and traits set by early life experience, several experts show that timing in development shapes outcomes that are hard to change later. It explains why early exposures, good and bad, carry outsized weight.
Fed versus fasted: how hormones switch your cells between burning and building
A biochemist, an obesity researcher and a longevity geneticist describe the same hormonal switch, with insulin, leptin and related signals telling cells whether to store, build or burn fuel. Understanding it clarifies why fasting, weight regain and metabolic disease are so tightly linked.
IKEA manuals, recipes and scratched CDs: the best metaphors for your genome
Researchers explain DNA as an instruction booklet, a recipe with typos and a CD whose information gets scratched with age, and each metaphor highlights a different truth about how genes work and fail. Comparing them gives non-scientists an intuitive model of inheritance, disease and aging.
Why promising molecules often disappoint: oxytocin, supplements and semaglutide
Oxytocin failed in autism trials while vasopressin showed promise, anti-aging supplements remain debated, and semaglutide works by pharmacology rather than natural physiology. These cases show how hard it is to turn an elegant biological mechanism into a treatment that actually helps people.
Worms, voles and songbirds: why odd animals unlock human genetics
Some of the biggest insights into inheritance, social behavior and speech came from C. elegans worms, prairie voles, monkeys and songbirds rather than from humans. The pattern explains why basic research on unglamorous organisms keeps paying off for medicine.
Can a pill slow aging? Sinclair's optimism versus Attia's skepticism
Sinclair frames aging as a treatable disease and is bullish on resetting cellular age, while Attia's reviews of metformin and NAD boosters find the evidence much weaker than the hype. Seeing both views side by side helps readers judge whether expensive longevity compounds are worth their money yet.
Food first, supplements second, with one micronutrient caveat
Attia and Mosconi stress that supplements cannot make up for poor diet, sleep and exercise, while Rhonda Patrick argues that common deficiencies in magnesium, vitamin D and omega-3s are worth correcting directly. Together they suggest a sensible order: fix foundations, then fill documented gaps.
Hormones and longevity: menopause, optimization and where experts draw lines
Mosconi links menopause to women's Alzheimer's risk, while Attia and Koniver discuss hormone optimization as a longevity lever with differing enthusiasm. Midlife hormone changes turn out to matter well beyond fertility and deserve informed attention.